https://www.thebodypro.com/author/kevin-fenton

Latest by Kevin A. Fenton, M.D., Ph.D.

Promo Image
Women

Interim Guidance for Clinicians Considering the Use of Pre-Exposure Prophylaxis for the Prevention of HIV Infection in Heterosexually Active Adults

In the United States, an estimated 48,100 new human immunodeficiency virus (HIV) infections occurred in 2009.1 Of these, 27% were in heterosexual men and women who did not inject drugs, and 64% were in men who have sex with men (MSM), including 3% in...

Promo Image
Women

Results of FEM-PrEP Clinical Trial Examining Pre-Exposure Prophylaxis (PrEP) for HIV Prevention Among Heterosexual Women

Dear Colleague,

Today, FHI announced that it will stop the FEM-PrEP study of pre-exposure prophylaxis (PrEP) for HIV prevention among heterosexual women. The decision was made after a regularly scheduled interim review of data by the trial's indepen...

Promo Image
News

Meeting the Need: A Blog Entry From Positive Policy

This article was cross-posted from the AIDS.gov blog. Kevin Fenton, M.D., Ph.D., FFPHis the director of the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC. (Cross-posted from Health Protection, Perspectives Blog.)

Last we...

Promo Image
Conference Coverage

Kevin Fenton of CDC Weighs in on the XVIII International AIDS Conference: A Blog Entry From Positive Policy

This article was cross-posted from the AIDS.gov blog. Kevin Fenton is the director of the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. (Cross-posted from the Health Protection, Perspectives blog, July 21, 2010.)

Greetings f...